Literature DB >> 16600318

Trend in incidence of hepatitis B virus infection during a decade of universal childhood hepatitis B vaccination in Saudi Arabia.

Tariq A Madani1.   

Abstract

Since 1990, the national strategy to eliminate hepatitis B virus (HBV) infection in Saudi Arabia has included universal administration of HBV vaccine to all infants. From 1990 to 1995 this vaccine was also routinely administered to children at school entry. The prevalence of hepatitis B surface antigen (HBsAg) among children before this programme was reported to be 6.7%. The objective of this study was to describe the trend in incidence of HBV infection over a decade of surveillance following the introduction of this programme. From January 1990 to December 1999 a total of 30,784 cases of HBV infection (positive for HBsAg) were reported. The total number of HBV infections among children <15 years of age was 4180 cases, with a prevalence of 0.05%. The total number of HBV infections among adults was 26,604 cases, with a prevalence of 0.22%. The prevalence varied by region, ranging from 0.03% to 0.72% with a mean prevalence of 0.15%. There was a clear decline in incidence among children whereas the incidence in adults slightly rose, perhaps owing to population growth estimated to be 3.3% annually. This study showed that the universal childhood HBV vaccination programme had an enormous positive impact on HBsAg seroprevalence among children in Saudi Arabia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16600318     DOI: 10.1016/j.trstmh.2005.12.003

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

1.  Hepatitis B Vaccine Coverage and the Immune Response in Children under ten years old in Sana'a, Yemen.

Authors:  Hassan A Al-Shamahy; Samira H Hanash; Iqbal A Rabbad; Nameem M Al-Madhaji; Samarih M Naser
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

Review 2.  The Emergent Concern of Hepatitis B globally with special attention to Kingdom of Saudi Arabia.

Authors:  Ahmad N Aljarbou
Journal:  Int J Health Sci (Qassim)       Date:  2013-11

3.  Prevalence of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infection among heroin injectors in the central region of Saudi Arabia.

Authors:  Abdulaziz T Alshomrani
Journal:  Saudi Med J       Date:  2015-07       Impact factor: 1.484

4.  SASLT practice guidelines: management of hepatitis C virus infection.

Authors:  Abdullah S Alghamdi; Faisal M Sanai; Mona Ismail; Hamdan Alghamdi; Khalid Alswat; Adel Alqutub; Ibrahim Altraif; Hemant Shah; Faleh Z Alfaleh
Journal:  Saudi J Gastroenterol       Date:  2012-09       Impact factor: 2.485

5.  Assessment of Immunization to Hepatitis B Vaccine among Children under Five Years in Rural Areas of Taiz, Yemen.

Authors:  Fuad A A Alssamei; Najla A Al-Sonboli; Fawzi A Alkumaim; Nader S Alsayaad; Mohammed S Al-Ahdal; Tarig B Higazi; Atif A Elagib
Journal:  Hepat Res Treat       Date:  2017-03-06

6.  Viral hepatitis B and C in HIV-infected patients in Saudi Arabia.

Authors:  Ahmad Alhuraiji; Ali Alaraj; Saad Alghamdi; Abdullah Alrbiaan; Abdulrahman A Alrajhi
Journal:  Ann Saudi Med       Date:  2014 May-Jun       Impact factor: 1.526

7.  The Correlation Between Hepatitis B Virus Precore/Core Mutations and the Progression of Severe Liver Disease.

Authors:  Ahmed A Al-Qahtani; Mashael R Al-Anazi; Nyla Nazir; Ayman A Abdo; Faisal M Sanai; Waleed K Al-Hamoudi; Khalid A Alswat; Hamad I Al-Ashgar; Mohammed Q Khan; Ali Albenmousa; Ahmed El-Shamy; Salah K Alanazi; Damian Dela Cruz; Marie Fe F Bohol; Mohammed N Al-Ahdal
Journal:  Front Cell Infect Microbiol       Date:  2018-10-22       Impact factor: 5.293

Review 8.  Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?

Authors:  Ayman A Abdo; Faisal M Sanai; Faleh Z Al-Faleh
Journal:  Saudi J Gastroenterol       Date:  2012 Nov-Dec       Impact factor: 2.485

9.  Hepatitis C virus infections reported in Saudi Arabia over 11 years of surveillance.

Authors:  Tariq A Madani
Journal:  Ann Saudi Med       Date:  2007 May-Jun       Impact factor: 1.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.